Enforcement Report - Week of April 10, 2024
10 Apr 2024 //
FDA
Enforcement Report - Week of February 7, 2024
07 Feb 2024 //
FDA
Enforcement Report - Week of December 21, 2022
21 Dec 2022 //
FDA
Enforcement Report - Week of August 17, 2022
17 Aug 2022 //
FDA
Enforcement Report - Week of June 8, 2022
08 Jun 2022 //
FDA
Hameln has received certificate “Union Format for Registration of Manufacturer
03 Jan 2022 //
PRESS RELEASE
Fresenius Kabi Introduces Simplist Prefilled Syringe
01 Sep 2021 //
CONTRACT PHARMA
Enforcement Report - Week of August 12, 2020
12 Aug 2020 //
FDA
Enforcement Report - Week of April 8, 2020
08 Apr 2020 //
FDA
Enforcement Report - Week of February 19, 2020
20 Feb 2020 //
FDA
Enforcement Report - Week of December 18, 2019
18 Dec 2019 //
FDA
Enforcement Report - Week of October 30, 2019
30 Oct 2019 //
FDA
Enforcement Report - Week of October 23, 2019
24 Oct 2019 //
FDA
Enforcement Report - Week of October 2, 2019
02 Oct 2019 //
FDA
Spectrum Laboratory Products Receives FDA Warning Letter
04 Jun 2019 //
FDA
Fresenius Kabi`s Generic Fentanyl Citrate Receives Approval in US
08 May 2019 //
FDA
Enforcement Report - Week of May 1, 2019
01 May 2019 //
FDA
Enforcement Report - Week of December 26, 2018
26 Dec 2018 //
FDA
Enforcement Report - Week of August 15, 2018
15 Aug 2018 //
FDA
Lawmaker urges Pfizer to sue over lethal injection procedure
30 Jul 2018 //
FIERCE PHARMA
Enforcement Report - Week of July 4, 2018
04 Jul 2018 //
Daiichi Sankyo launches Fentanyl Citrate Tape for 1day “Daiichi Sankyo” in Japan
15 Jun 2018 //
PHARMABIZ
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
Enforcement Report - Week of February 14, 2018
14 Feb 2018 //
FDA
Actavis Lab’s Generic Fentanyl Citrate Receives Approval In US
21 Nov 2017 //
FDA
Enforcement Report - Week of November 1, 2017
01 Nov 2017 //
FDA
Enforcement Report - Week of September 27, 2017
28 Sep 2017 //
FDA
BioDelivery, Collegium Pharma Announce Licensing Agreement for ONSOLIS®
11 May 2016 //
PR NEWSWIRE
Pharmedium Services, LLC recalls fentaNYL Citrate due to Subpotent Drug
24 Feb 2016 //
FDA
Depomed Issues Statement on Horizon Pharma plc`s Unsolicited Exchange Offer
08 Sep 2015 //
PR NEWS WIRE